BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Tuesday, March 10, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 16, 2007
View Archived Issues
CP-4126 well tolerated in solid tumor patients
Read More
Orphan Europe seeks EMEA approval of Vedrop for vitamin E deficiencies
Read More
Desvenlafaxine improves hot flushes, mood in postmenopausal women
Read More
Alcon submits amendment to NDA for Patanase
Read More
Lupin acquires majority stake in Kyowa
Read More
Wyeth and Zealand begin phase I trials on ZP-1609
Read More
FDA grants orphan drug status to recombinant fibrinogen
Read More
Enrollment complete for phase III clinical trial of pravastatin combination therapy
Read More
FDA denies approval of CX-717 clinical trials for ADHD
Read More
Affymax begins patient dosing in phase III trial of Hematide
Read More
Partial response rate reported in Davant phase II trial for colorectal cancer
Read More
Momenta evaluates M-118 in broad ACS clinical program
Read More
NS-1738, an allosteric modulator of alpha7 nAChRs improves short- and long-term memory in vivo
Read More
Phase III study of Gattex demonstrates clinical benefits
Read More
Series B financing by Metastatix to support cancer drug clinical trials
Read More
SpirH begins phase II study and opens enrollment for worldwide clinic participation
Read More
NPS sells mGluR collaboration assets to AstraZeneca
Read More
Novel NO donor shows potential in inflammatory skin conditions
Read More
Doribax approved by FDA for the treatment of cIAI and cUTI
Read More
Gilead submits marketing applications for Viread in U.S. and E.U.
Read More
NDA for Ampligen submitted by Hemispherx Biopharma
Read More
FDA approves use of Lexiva with reduced dose of ritonavir
Read More
Clinical data on PEP-005 topical gel for skin cancers presented
Read More
Recent Janssen and Astellas patents report novel therapeutic agents for thrombotic disorders
Read More
New agents for treating neurological disorders disclosed in recent patent literature
Read More
Recent patents describe new treatment options for cardiovascular disorders
Read More
The ACAT inhibitor KY-382 shows antiatherosclerotic effects in rabbits
Read More
Tamoxifen for the treatment of acute mania / News in Context
Read More
